Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells

Area of Science:

• Immunology
• Cell Biology
• Therapeutic Antibody Development

Background:

• CD4 T cells play a crucial role in immune responses.
• Dysregulation of CD4 T cells is implicated in autoimmune diseases.
• Anti-CD4 antibodies are being investigated as potential therapeutics.

Purpose of the Study:

• To investigate the effects of a fully humanized anti-CD4 antibody on resting and activated CD4 T cells.
• To explore the mechanisms of CD4 down-modulation by the antibody.
• To assess the therapeutic potential of anti-CD4 antibodies in autoimmune disease.

Main Methods:

• Treatment of resting and activated CD4 T cells with a humanized anti-CD4 antibody.
• Analysis of CD4 expression levels via flow cytometry and Western blot.
• Investigation of Fc receptor (FcR)-mediated cross-linking requirements.
• Assessment of effects on other cell surface markers.

Main Results:

• The antibody induced significant down-modulation of CD4 expression on both resting and activated CD4 T cells.
• FcR-mediated cross-linking was essential for CD4 down-modulation on resting T cells but not activated T cells.
• On activated T cells, antibody treatment affected multiple cell surface markers beyond CD4.
• Western blot analysis confirmed reduced total cellular CD4, with remaining CD4 associated with p56lck.

Conclusions:

• Humanized anti-CD4 antibodies can effectively down-modulate CD4 expression.
• The mechanism of action and affected markers differ between resting and activated T cells.
• These findings support the consideration of anti-CD4 antibodies for autoimmune disease therapy, highlighting the importance of antibody isotype selection.